Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net income (loss) $ (26,183) $ (12,723)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 5,678 5,084
Amortization of debt issuance costs and discount 349 173
Equity-based compensation expense 4,453 3,866
(Gain) loss on sale of joint ventures (1,303) 0
(Gain) loss on change in fair value of committed equity facility 0 (66)
(Gain) loss on change in fair value of warrants 10,052 2,011
Deferred provision (benefit) for income taxes 112 (333)
Non-cash lease expense 22 103
Non-cash interest expense 0 525
Other 690 (128)
Changes in assets and liabilities:    
(Increase) decrease in accounts receivable 9,987 1,376
(Increase) decrease in contract assets (6,449) (11,898)
(Increase) decrease in inventory (314) 188
(Increase) decrease in prepaid insurance 505 1,604
(Increase) decrease in prepaid expenses and other assets (231) (592)
Increase (decrease) in accounts payable and accrued expenses 4,838 (3,262)
Increase (decrease) in deferred revenue (8,497) 4,025
Increase (decrease) in operating lease liabilities (169) (160)
Increase (decrease) in other liabilities (282) (440)
Increase (decrease) in notes payable to sellers 0 (557)
Net cash provided by (used in) operating activities (6,742) (11,204)
Cash flows from investing activities:    
Net proceeds from sale of joint ventures 4,598 0
Purchases of property, plant and equipment, net (2,475) (2,223)
Purchase of intangible assets (1,579) (325)
Net cash provided by (used in) investing activities 544 (2,548)
Cash flows from financing activities:    
Proceeds received from debt 15,000 11,500
Repayments of debt (7,988) (13,695)
Payment of debt issuance fees to third parties (322) 0
Repayment of finance leases (235) (175)
Proceeds from issuance of common stock 530 0
Payment of committed equity facility transaction costs 0 (571)
Payments of issuance costs related to convertible preferred stock 0 (52)
Shares repurchased for settlement of employee tax withholdings on share-based awards (56) 0
Payment of contingent earnout 0 (443)
Net cash provided by (used in) financing activities 6,929 (3,436)
Effect of foreign currency rate changes on cash and cash equivalents (177) 103
Net increase (decrease) in cash and cash equivalents 554 (17,085)
Cash and cash equivalents at beginning of period 30,278 28,316
Cash and cash equivalents at end of period $ 30,832 $ 11,231